Aspirin for Prophylaxis of TTP

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2028

Conditions
Thrombotic Thrombocytopenic Purpura
Interventions
DRUG

Aspirin tablet

When patients are randomized into the intervention group, they will receive aspirin at the dosage of 100mg orally once every day.

DRUG

Placebo

When patients are randomized into the placebo group, they will receive placebo orally once a day.

All Listed Sponsors
lead

The First Affiliated Hospital of Soochow University

OTHER

NCT05568147 - Aspirin for Prophylaxis of TTP | Biotech Hunter | Biotech Hunter